Table 1 Clinicopathological characteristics of PNET patients
Clinicopathological features of patients with PNETs | Number | |
|---|---|---|
Gender n = 89 (%) | Male | 36 (40.4) |
| Â | Female | 53 (59.6) |
| Â | Male : Female | 1:1.47 |
Age (years) at diagnosis, n = 87 | Median (range) | 47 (16–74) |
PNET subtype n = 89 (%) | Insulinoma | 57 (64.0) |
| Â | Non-insulinoma | 32 (36.0) |
| Â | NF | 19 (21.3) |
| Â | gastrinoma | 8 (9.0) |
| Â | glucagonoma | 4 (4.5) |
| Â | VIPoma | 1 (1.1) |
Inherited or sporadic PNETs, n = 89 (%) | Sporadic | 86 (96.6) |
| Â | MEN-1 associated | 3 (3.4) |
Surgery or not, n = 89 (%) | Resection | 73 (82.0) |
| Â | Unresection | 16 (18.0) |
Primary tumor location, n = 77 (%) | Pancreatic head/neck | 40 (51.9) |
| Â | Pancreatic body/tail | 36 (46.8) |
| Â | duodenum | 1 (1.3) |
Tumor size (cm) median (range) n = 82 |  | 1.6 (0.8-8) |
|  | Insulinoma n = 56 | 1.5 (0.8-4) |
|  | Non-insulinoma n = 26 | 4.3 (1.5-8) |
Metastasis or not, n = 83 (%) | No | 65 (78.3) |
| Â | Yes | 18 (21.7) |
Grade, n = 54 (%) | G1 | 37 (68.5) |
| Â | G2 | 15 (27.8) |
| Â | G3 | 2 (3.7) |
Stage, n = 84 (%) | I | 39 (46.4) |
| Â | II | 22 (26.2) |
| Â | III | 5 (6.0) |
| Â | IV | 18 (21.4) |
Clinicopathological features of patients with insulinomas | Number | |
Gender n = 57 (%) | Male | 25 (43.9) |
| Â | Female | 32 (56.1) |
| Â | Male : Female | 1:1.28 |
Age (years) at diagnosis, n = 57 | Median (range) | 47 (16–74) |
Inherited or sporadic PNETs, n = 57 (%) | Sporadic | 55 (96.5) |
| Â | MEN-1 associated | 2 (3.5) |
Surgery or not, n = 57 (%) | Resection | 54 (94.7) |
| Â | Unresection | 3 (5.3) |
Primary tumor location, n = 56 (%) | Pancreatic head/neck | 30 (53.6) |
| Â | Pancreatic body/tail | 26 (46.4) |
Tumor size (cm) median (range) n = 56 |  | 1.5 (0.8-4) |
Metastasis or not, n = 57 (%) | No | 56 (98.2) |
| Â | Yes | 1 (1.8) |
Grade, n = 35 (%) | G1 | 31 (88.6) |
| Â | G2 | 4 (11.4) |